Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia

NCT02575235 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02575235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02575235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia
Lead sponsor
Seoul National University Hospital
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2015
Completion date
July 1, 2016
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcopenia